-
2025 COMB丨Professor Fei Ma: New Perspectives in Breast Cancer Immunotherapy—Mechanistic Insights, Adverse Event Management, and Precision Pathways
Synergistic Mechanisms of Metronomic Chemotherapy with Immunotherapy Oncology Frontier:Your team’s phase II prospective randomized study suggested significant differences in synergy between immunotherapy and various chemotherapy regimens. Mechanistically, how does metronomic…
-
EBMT President-Elect Professor Ibrahim Yakoub-Agha: Allogeneic Hematopoietic Stem Cell Transplantation for Myeloproliferative Neoplasms
Part 1 Oncology Frontier – Hematology Frontier: In current clinical practice, where JAK inhibitors are often used as a bridge to transplantation, how do you determine the optimal timing for…
-
2025 COMB丨Professor Jiayu Wang: Balancing Individualized Treatment and Liver Function Preservation in Breast Cancer Liver Metastases
Epidemiology of Breast Cancer Liver Metastases Oncology Frontier: Liver metastasis is one of the most common sites of distant spread in breast cancer and a major therapeutic challenge. Could you…
-
Professor Bing Han: Treatment Strategies for Aplastic Anemia in the TPO-RA Era
Editor’s Note: The 13th Ludaopei Hematology Academic Conference, jointly organized by the Beijing Health Promotion Association and the Hongmian Tumor and Rare Disease Public Welfare Foundation, and hosted by the…
-
Professor Robert Negrin, ASH President-Elect: Immunoregulatory Mechanisms to Improve Transplant Outcomes
Editor’s Note: The 13th Ludaopei Hematology Academic Conference, jointly organized by the Beijing Health Promotion Association and the Guangzhou Hongmian Tumor and Rare Disease Public Welfare Foundation and hosted by…
Connecting Medical Expertise through Media